Literature DB >> 23415801

Pathology of rodent models of intestinal cancer: progress report and recommendations.

Mary Kay Washington1, Anne E Powell, Ruth Sullivan, John P Sundberg, Nicholas Wright, Robert J Coffey, William F Dove.   

Abstract

In October 2010, a pathology review of rodent models of intestinal neoplasia was held at The Jackson Laboratory. This review complemented 2 other concurrent events: a workshop on methods of modeling colon cancer in rodents and a conference on current issues in murine and human colon cancer. We summarize the results of the pathology review and the committee's recommendations for tumor nomenclature. A virtual high-resolution image slide box of these models has been developed. This report discusses significant recent developments in rodent modeling of intestinal neoplasia, including the role of stem cells in cancer and the creation of models of metastatic intestinal cancer.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23415801      PMCID： PMC3660997          DOI： 10.1053/j.gastro.2013.01.067

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


  67 in total

1.  Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.

Authors:  Nina M Muñoz; Melissa Upton; Andres Rojas; M Kay Washington; Li Lin; Anna Chytil; Elif G Sozmen; Blair B Madison; Ambra Pozzi; Randall T Moon; Harold L Moses; William M Grady
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

2.  Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice.

Authors:  Nicole M Sodir; Xuan Chen; Ryan Park; Andrea E Nickel; Peter S Conti; Rex Moats; James R Bading; Darryl Shibata; Peter W Laird
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

3.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

Authors:  Julia Bollrath; Toby J Phesse; Vivian A von Burstin; Tracy Putoczki; Moritz Bennecke; Trudie Bateman; Tim Nebelsiek; Therese Lundgren-May; Ozge Canli; Sarah Schwitalla; Vance Matthews; Roland M Schmid; Thomas Kirchner; Melek C Arkan; Matthias Ernst; Florian R Greten
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

4.  Crypt stem cells as the cells-of-origin of intestinal cancer.

Authors:  Nick Barker; Rachel A Ridgway; Johan H van Es; Marc van de Wetering; Harry Begthel; Maaike van den Born; Esther Danenberg; Alan R Clarke; Owen J Sansom; Hans Clevers
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962

Review 5.  Mouse models of colon cancer.

Authors:  Makoto Mark Taketo; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-03       Impact factor: 22.682

6.  Transcription factor achaete scute-like 2 controls intestinal stem cell fate.

Authors:  Laurens G van der Flier; Marielle E van Gijn; Pantelis Hatzis; Pekka Kujala; Andrea Haegebarth; Daniel E Stange; Harry Begthel; Maaike van den Born; Victor Guryev; Irma Oving; Johan H van Es; Nick Barker; Peter J Peters; Marc van de Wetering; Hans Clevers
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

7.  Identification of mucin depleted foci in the human colon.

Authors:  Angelo Pietro Femia; Augusto Giannini; Marilena Fazi; Elena Tarquini; Maddalena Salvadori; Luca Roncucci; Francesco Tonelli; Piero Dolara; Giovanna Caderni
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

8.  A transposon-based genetic screen in mice identifies genes altered in colorectal cancer.

Authors:  Timothy K Starr; Raha Allaei; Kevin A T Silverstein; Rodney A Staggs; Aaron L Sarver; Tracy L Bergemann; Mihir Gupta; M Gerard O'Sullivan; Ilze Matise; Adam J Dupuy; Lara S Collier; Scott Powers; Ann L Oberg; Yan W Asmann; Stephen N Thibodeau; Lino Tessarollo; Neal G Copeland; Nancy A Jenkins; Robert T Cormier; David A Largaespada
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

9.  Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.

Authors:  Owen J Sansom; Valerie Meniel; Julie A Wilkins; Alicia M Cole; Karin A Oien; Victoria Marsh; Thomas J Jamieson; Carmen Guerra; Gabrielle H Ashton; Mariano Barbacid; Alan R Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-07       Impact factor: 11.205

10.  Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.

Authors:  Liqin Zhu; Paul Gibson; D Spencer Currle; Yiai Tong; Robert J Richardson; Ildar T Bayazitov; Helen Poppleton; Stanislav Zakharenko; David W Ellison; Richard J Gilbertson
Journal:  Nature       Date:  2008-12-17       Impact factor: 49.962
View more
  53 in total

1.  Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones.

Authors:  James M Amos-Landgraf; Jarom Heijmans; Mattheus C B Wielenga; Elisa Dunkin; Kathy J Krentz; Linda Clipson; Antwan G Ederveen; Patrick G Groothuis; Sietse Mosselman; Vanesa Muncan; Daniel W Hommes; Alexandra Shedlovsky; William F Dove; Gijs R van den Brink
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 2.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

3.  Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer.

Authors:  Amy A Irving; Lori A Plum; William J Blaser; Madeline R Ford; Chao Weng; Linda Clipson; Hector F DeLuca; William F Dove
Journal:  J Nutr       Date:  2014-12-24       Impact factor: 4.798

4.  Multiscale analysis of the murine intestine for modeling human diseases.

Authors:  Jesse Lyons; Charles A Herring; Amrita Banerjee; Alan J Simmons; Ken S Lau
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

5.  Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy.

Authors:  Stephen N Housley; Paul Nardelli; Dario I Carrasco; Travis M Rotterman; Emily Pfahl; Lilya V Matyunina; John F McDonald; Timothy C Cope
Journal:  Cancer Res       Date:  2020-04-28       Impact factor: 12.701

6.  Thymoquinone potentiates chemoprotective effect of Vitamin D3 against colon cancer: a pre-clinical finding.

Authors:  Amr M Mohamed; Bassem A Refaat; Adel G El-Shemi; Osama A Kensara; Jawwad Ahmad; Shakir Idris
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

7.  A simple, quantitative method using alginate gel to determine rat colonic tumor volume in vivo.

Authors:  Amy A Irving; Lindsay B Young; Jennifer K Pleiman; Michael J Konrath; Blake Marzella; Michael Nonte; Justin Cacciatore; Madeline R Ford; Linda Clipson; James M Amos-Landgraf; William F Dove
Journal:  Comp Med       Date:  2014-04       Impact factor: 0.982

8.  Pathology Principles and Practices for Analysis of Animal Models.

Authors:  Sue E Knoblaugh; Tobias M Hohl; Krista M D La Perle
Journal:  ILAR J       Date:  2018-12-01

9.  Knockout of ClC-2 reveals critical functions of adherens junctions in colonic homeostasis and tumorigenicity.

Authors:  Younggeon Jin; Dina Ibrahim; Scott T Magness; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-04       Impact factor: 4.052

10.  Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer by Inhibiting GSK-3β.

Authors:  Shakir M Saud; Weidong Li; Zane Gray; Matthias S Matter; Nancy H Colburn; Matthew R Young; Young S Kim
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.